Both Glimepiride and High-Dose Metformin Are Important for Sustained Glucose Lowering in Japanese Type 2 Diabetes Patients on Glimepiride–Sitagliptin–Metformin Therapy: Subanalysis of a Single-Center, Open-Label, Randomized Study

Diabetes Technology & Therapeutics , Vol. 0, No. 0.
Source: Diabetes Technology - Category: Endocrinology Tags: article Source Type: research